Skip to content

Contemporary Clinical Management Of Acute Pulmonary Embolism

Contemporary Clinical Management Of Acute Pulmonary Embolism. The COPE Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03631810
Acronym
COPE
Enrollment
5213
Registered
2018-08-15
Start date
2018-03-15
Completion date
2021-02-17
Last updated
2021-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pulmonary Embolism

Keywords

Acute pulmonary embolism, International guidelines

Brief summary

Acute pulmonary embolism is a potentially life-threatening disease with short-term mortality ranges from less than 1% to more than 30% during the hospital stay. Recent guidelines recommend to tailor diagnosis hospitalization and acute treatment based on the estimated risk for short-term Death. The assessment of the contemporary clinical management of patients with acute pulmonary embolism across different specialties would be of crucial value.

Detailed description

This is a prospective, non-interventional, multicenter study in patients with acute pulmonary embolism admitted to Cardiology, Emergency and Internal Medicine Departments in Italy. The aim of the study is to assess contemporary management strategies in patients with acute pulmonary embolism in terms of diagnosis, risk stratification, hospitalization and treatment in Italy and assess 1. their association with in-hospital and 30-day mortality and 2. their adherence to current guidelines of the European Society of Cardiology (ESC).

Interventions

None listed

Sponsors

University Of Perugia
CollaboratorOTHER
Heart Care Foundation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with acute, symptomatic acute pulmonary embolism * Age ≥ 18 years * Informed consent

Exclusion criteria

* refusal of informed consent * participation in controlled trials on the management of patients with acute pulmonary embolism

Design outcomes

Primary

MeasureTime frameDescription
In-hospital death30 daysIn-hospital Death and Death at 30 days

Secondary

MeasureTime frameDescription
All cause Mortality and clinical worsening30 daysDeath or clinical deterioration at 30 days from the diagnosis of pulmonary embolism
Pulmonary embolism related mortality for and clinical worsening30 daysPulmonary embolism-related death or clinical deterioration at 30 days from the diagnosis of pulmonary embolismembolism
Adherence to guidelines30 daysAdherence to current guidelines on the management of acute pulmonary embolism released by the ESC regarding diagnosis, risk stratification and treatment

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026